Ramucirumab plus nivolumab shows promising antitumor activity in phase I/II NivoRam study Jan. 23, 2019
Margetuximab plus pembrolizumab shows promising activity in HER2+ (IHC3+) gastric carcinoma Jan. 23, 2019
Voclosporin ophthalmic solution demonstrates statistically superior efficacy versus Restasis Jan. 23, 2019
Results from dose-selection trial of H56:IC31 vaccine candidate in tuberculosis-endemic populations Jan. 23, 2019
RSS